Skip to main content
Erschienen in: Rheumatology International 5/2011

01.05.2011 | Original Article

Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis

verfasst von: Elaudi Rodríguez-Polanco, Soham Al Snih, Yong-Fang Kuo, Alberto Millán, Martín A. Rodríguez

Erschienen in: Rheumatology International | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

A retrospective study in a hospital-based sample of Venezuelan patients with rheumatoid arthritis was made to estimate the lag time between onset of symptoms, diagnosis, and initiation of DMARD treatment. Medical records and in-person interview of patients to fill in a questionnaire collecting information on demographics and initiation of symptoms, first consultation with any physician, time of diagnosis, and initiation of first disease-modifying anti-rheumatic drug were reviewed. We performed descriptive statistics and multivariable linear regression analysis. Mean lag time between symptom onset and diagnosis of rheumatoid arthritis was 40.5 months (range 1–424). Mean lag time between onset of symptoms and first consultation with a physician and between first consultation and diagnosis was 16.3 and 23.9 months, respectively. Mean lag time between onset of symptoms and initiation of DMARD treatment was 56.9 months. A definitive diagnosis of rheumatoid arthritis was done by a rheumatologist in 251 patients (92.3%). First consultation with an orthopedist or a primary care physician, first consultation in a public versus a private health center, and diagnosis before 2000 were associated with longer lag time between onset of symptoms and diagnosis. Venezuelan patients with rheumatoid arthritis had a marked delay from disease onset to diagnosis and initiation of first DMARD. First consultation with an orthopedist and consultation in a public versus a private health center were the variables with the strongest effect on lag time to diagnosis and to initiation of first DMARD.
Literatur
1.
Zurück zum Zitat Bjelle A, Mägi M (1981) Rheumatic disorders in primary care: study of two primary care centers and a review of previous Swedish reports on primary care Scand. J Rheumatol 10:331–341 Bjelle A, Mägi M (1981) Rheumatic disorders in primary care: study of two primary care centers and a review of previous Swedish reports on primary care Scand. J Rheumatol 10:331–341
2.
Zurück zum Zitat Aletaha D, Eberl G, Nell VPK, Machold KP, Smolen JS (2002) Practical progress in realisation of early diagnosis and treatment in patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 61:630–634PubMedCrossRef Aletaha D, Eberl G, Nell VPK, Machold KP, Smolen JS (2002) Practical progress in realisation of early diagnosis and treatment in patients with suspected rheumatoid arthritis: results from two matched questionnaires within three years. Ann Rheum Dis 61:630–634PubMedCrossRef
3.
Zurück zum Zitat van der Heidi A, Jacobs JWG, Bijlsma JWJ et al (1996) The benefits of early treatment with “second-line” antirheumatic drugs: a randomised, controlled trial. Ann Intern Med 124:699–706 van der Heidi A, Jacobs JWG, Bijlsma JWJ et al (1996) The benefits of early treatment with “second-line” antirheumatic drugs: a randomised, controlled trial. Ann Intern Med 124:699–706
4.
Zurück zum Zitat Egsmose C, Lund B, Borg G et al (1995) Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-year follow-up of a prospective double blind placebo controlled study. J Rheumatol 22:2208–2213PubMed Egsmose C, Lund B, Borg G et al (1995) Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5-year follow-up of a prospective double blind placebo controlled study. J Rheumatol 22:2208–2213PubMed
5.
Zurück zum Zitat Mottonen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial. FIN-RACO trial group. Lancet 353:1568–1573PubMedCrossRef Mottonen T, Hannonen P, Leirisalo-Repo M et al (1999) Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial. FIN-RACO trial group. Lancet 353:1568–1573PubMedCrossRef
6.
Zurück zum Zitat Irvine S, Munro R, Porter D (1999) Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 58:510–513PubMedCrossRef Irvine S, Munro R, Porter D (1999) Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 58:510–513PubMedCrossRef
7.
Zurück zum Zitat Boers M (2003) Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 48:1771–1774PubMedCrossRef Boers M (2003) Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 48:1771–1774PubMedCrossRef
8.
Zurück zum Zitat van der Heijde DMFM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34(Suppl 2):74–78PubMed van der Heijde DMFM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34(Suppl 2):74–78PubMed
9.
Zurück zum Zitat Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, Pope JE, Keystone EC (2004) Canadian consensus statement on early optimal therapy of rheumatoid arthritis. J Can Rheumatol Assoc (Autumn) 11-3 Bykerk VP, Baron M, Boire G, Haraoui B, Khraishi M, LeClercq S, Pope JE, Keystone EC (2004) Canadian consensus statement on early optimal therapy of rheumatoid arthritis. J Can Rheumatol Assoc (Autumn) 11-3
10.
Zurück zum Zitat Fuchs HA, Kaye JJ, Kallahan LF et al (1989) Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585–591PubMed Fuchs HA, Kaye JJ, Kallahan LF et al (1989) Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585–591PubMed
11.
Zurück zum Zitat Chan KA, Nelson DT, Walter AM (1994) The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814–820PubMedCrossRef Chan KA, Nelson DT, Walter AM (1994) The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 37:814–820PubMedCrossRef
12.
Zurück zum Zitat Gray M, Nuki G (2001) Audit of delay between symptom onset and commencement of disease modifying anti-rheumatic drugs (DMARDs) in patients with newly diagnosed rheumatoid arthritis referred to a hospital rheumatology unit. Rheumatology 40(Suppl. 1):60 Gray M, Nuki G (2001) Audit of delay between symptom onset and commencement of disease modifying anti-rheumatic drugs (DMARDs) in patients with newly diagnosed rheumatoid arthritis referred to a hospital rheumatology unit. Rheumatology 40(Suppl. 1):60
13.
Zurück zum Zitat Bashda H, Kong KO, Tak PP (2007) Rheumatoid arthritis in Dubai: delayed diagnosis and low usage of disease modifying antirheumatic drugs. Ann Rheum Dis 66:835CrossRef Bashda H, Kong KO, Tak PP (2007) Rheumatoid arthritis in Dubai: delayed diagnosis and low usage of disease modifying antirheumatic drugs. Ann Rheum Dis 66:835CrossRef
14.
Zurück zum Zitat Palm O, Purinszky E (2005) Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 64:1227–1228PubMedCrossRef Palm O, Purinszky E (2005) Women with early rheumatoid arthritis are referred later than men. Ann Rheum Dis 64:1227–1228PubMedCrossRef
15.
Zurück zum Zitat Xibillié-Friedman D, Mondragón-Flores V, Horcasitas de la Rosa C (2006) Criteria used by primary care physicians for the diagnosis and the referral to a rheumatologist of patients with rheumatoid arthritis. Reumatol Clin 2:235–238CrossRef Xibillié-Friedman D, Mondragón-Flores V, Horcasitas de la Rosa C (2006) Criteria used by primary care physicians for the diagnosis and the referral to a rheumatologist of patients with rheumatoid arthritis. Reumatol Clin 2:235–238CrossRef
16.
Zurück zum Zitat Palleiro D (2006) Diagnostic delay in rheumatoid arthritis. J Clin Rheumatol 12:S41CrossRef Palleiro D (2006) Diagnostic delay in rheumatoid arthritis. J Clin Rheumatol 12:S41CrossRef
17.
Zurück zum Zitat Massardo L, Aguirre V, García ME, Cervilla V, Nicovani S, González A et al (1995) Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum 25:203–213PubMedCrossRef Massardo L, Aguirre V, García ME, Cervilla V, Nicovani S, González A et al (1995) Clinical expression of rheumatoid arthritis in Chilean patients. Semin Arthritis Rheum 25:203–213PubMedCrossRef
18.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
19.
Zurück zum Zitat Graffar M (1956) Une methode de classification sociales d′chantillons de populations. Courrier 6:445–459 Graffar M (1956) Une methode de classification sociales d′chantillons de populations. Courrier 6:445–459
20.
Zurück zum Zitat Mendez-Castellanos H, Mendez MC (1986) Estratificación social y biología humana: Método Graffar modificado. Arch Puer Ped 49:93–104 Mendez-Castellanos H, Mendez MC (1986) Estratificación social y biología humana: Método Graffar modificado. Arch Puer Ped 49:93–104
21.
Zurück zum Zitat Feldman DE, Bertnasky S, Haggerty J, Leffondré K, Tousignant P, Roy Y et al (2007) Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum (Arthritis Care Res) 57:1419–1425CrossRef Feldman DE, Bertnasky S, Haggerty J, Leffondré K, Tousignant P, Roy Y et al (2007) Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum (Arthritis Care Res) 57:1419–1425CrossRef
22.
Zurück zum Zitat Van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JMW (1998) Diagnosis and course of early-onset arthritis: Results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37:1084–1088PubMedCrossRef Van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JMW (1998) Diagnosis and course of early-onset arthritis: Results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 37:1084–1088PubMedCrossRef
23.
Zurück zum Zitat Latin American Rheumatology Associations of the Pan-American League of Associations (PANLAR), Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR) (2006) Rheumatology 45:ii7–ii22 Latin American Rheumatology Associations of the Pan-American League of Associations (PANLAR), Grupo Latinoamericano de Estudio de Artritis Reumatoide (GLADAR) (2006) Rheumatology 45:ii7–ii22
24.
Zurück zum Zitat Criswell LA, Such CL, Yelin EH (1997) Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 24:2283–2290PubMed Criswell LA, Such CL, Yelin EH (1997) Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 24:2283–2290PubMed
25.
Zurück zum Zitat Hooker RS, Brown JB (1990) Rheumatology referral patterns. HMO Practice 4:61–65PubMed Hooker RS, Brown JB (1990) Rheumatology referral patterns. HMO Practice 4:61–65PubMed
26.
Zurück zum Zitat Lacaille D, Anis AH, Guh DP, Esdaile JM (2005) Gaps for care in rheumatoid arthritis: a population study. Arthritis Rheum (Arthritis Care Res) 53:241–248CrossRef Lacaille D, Anis AH, Guh DP, Esdaile JM (2005) Gaps for care in rheumatoid arthritis: a population study. Arthritis Rheum (Arthritis Care Res) 53:241–248CrossRef
27.
Zurück zum Zitat Gámez-Nava JI, González-López L, Davies P, Suárez-Almazor ME (1998) Referral and diagnosis of common rheumatic diseases by primary care physicians. Rheumatology 37:1215–1219CrossRef Gámez-Nava JI, González-López L, Davies P, Suárez-Almazor ME (1998) Referral and diagnosis of common rheumatic diseases by primary care physicians. Rheumatology 37:1215–1219CrossRef
28.
Zurück zum Zitat Sverdup B, Allebeck P, Allender E (1993) Tentative diagnoses among referrals versus diagnosis established at the department of rheumatology. Scand J Rheumatol 12:377–378CrossRef Sverdup B, Allebeck P, Allender E (1993) Tentative diagnoses among referrals versus diagnosis established at the department of rheumatology. Scand J Rheumatol 12:377–378CrossRef
29.
Zurück zum Zitat Bolumar S, Ruiz M, Hernandez I, Pascual E (1994) Reliability of the diagnosis of the rheumatic diseases at the primary health care level. J Rheumatol 21:2344–2348PubMed Bolumar S, Ruiz M, Hernandez I, Pascual E (1994) Reliability of the diagnosis of the rheumatic diseases at the primary health care level. J Rheumatol 21:2344–2348PubMed
30.
Zurück zum Zitat Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–2328PubMed Hernández-García C, Vargas E, Abásolo L, Lajas C, Bellajdell B, Morado IC et al (2000) Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 27:2323–2328PubMed
31.
Zurück zum Zitat Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCrossRef Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCrossRef
32.
Zurück zum Zitat Nell VP, Machold KP, Eberl G, Stam TA, Uffman M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43:906–914PubMedCrossRef Nell VP, Machold KP, Eberl G, Stam TA, Uffman M, Smolen JS (2004) Benefit of very early referral and very early therapy with disease modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43:906–914PubMedCrossRef
33.
Zurück zum Zitat American College of Rheumatology (2002) Guidelines for the management of rheumatoid arthritis 2002 update. Arthritis Rheum 46:328–346CrossRef American College of Rheumatology (2002) Guidelines for the management of rheumatoid arthritis 2002 update. Arthritis Rheum 46:328–346CrossRef
Metadaten
Titel
Lag time between onset of symptoms and diagnosis in Venezuelan patients with rheumatoid arthritis
verfasst von
Elaudi Rodríguez-Polanco
Soham Al Snih
Yong-Fang Kuo
Alberto Millán
Martín A. Rodríguez
Publikationsdatum
01.05.2011
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1358-9

Weitere Artikel der Ausgabe 5/2011

Rheumatology International 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.